RSS   Newsletter   Contact   Advertise with us

Teva says CFO Michael McClellan will step down

Share on Twitter Share on LinkedIn
Christian Fernsby | Jerusalem, Israel | August 7, 2019
Michael McClellanTeva Pharmaceutical Industries announced that Michael McClellan, executive vice president and chief financial officer, has decided to step down from his role as CFO due to personal reasons.
Mr. McClellan was appointed Teva's CFO in November 2017 after serving as Senior Vice President and Interim Group Chief Financial Officer from July 2017.

From 2015 to November 2017, Mr. McClellan served as Senior Vice President and CFO, Global Specialty Medicines.


POST Online Media Contact